Home > Income Statement > LINCOLN PHARMACEUTICALS

LINCOLN PHARMACEUTICALS
Revenue

    Back to Income Statement
LINCOLN PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for LINCOLN PHARMACEUTICALS
Please provide your vote to see the results

LINCOLN PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹581 Cr₹510 Cr₹472 Cr₹424 Cr₹386 Cr

What is the latest Revenue of LINCOLN PHARMACEUTICALS ?

The latest Revenue ratio of LINCOLN PHARMACEUTICALS is ₹581 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹581 Cr
Mar2024₹510 Cr
Mar2023₹472 Cr
Mar2022₹424 Cr
Mar2021₹386 Cr

How is Revenue of LINCOLN PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹581 Cr
13.76
Mar2024 ₹510 Cr
8.09
Mar2023 ₹472 Cr
11.30
Mar2022 ₹424 Cr
9.75
Mar2021 ₹386 Cr -

Compare Revenue of peers of LINCOLN PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS ₹1,225.7 Cr 2.9% 2.1% 2.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹461,848.0 Cr -1.4% -1.3% 21.5% Stock Analytics
DIVIS LABORATORIES ₹225,648.0 Cr 2.7% 16.1% 38.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹184,109.0 Cr -1.5% -3.3% 35.6% Stock Analytics
CIPLA ₹117,139.0 Cr -0.7% 1.4% -2% Stock Analytics
DR REDDYS LABORATORIES ₹100,328.0 Cr 3.9% -1.8% 0.4% Stock Analytics


LINCOLN PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
LINCOLN PHARMACEUTICALS

2.9%

2.1%

2.3%

SENSEX

-0.6%

1.1%

-3.2%


You may also like the below Video Courses